Citigroup
AVNS

Citigroup’s Avanos Medical AVNS Stock Holding History

Citigroup’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,792
Closed -$193K – 7542
2015
Q3 		$193K Sell
6,792
-768
-10% -$26.8K ﹤0.01% 4520
2015
Q2 		$306K Sell
7,560
-2,280
-23% -$102K ﹤0.01% 4117
2015
Q1 		$484K Sell
9,840
-12,072
-55% -$559K ﹤0.01% 3771
2014
Q4 		$996K Buy
+21,912
New +$861K ﹤0.01% 3142

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Citigroup's AVNS Position: Q2 2026 in Review

Citigroup increased its Avanos Medical (AVNS) stake by 675% in Q2 2026, buying an estimated $1.64M and bringing the position to 80,193 shares worth $2M. The position accounts for ﹤0.01% of the portfolio, ranked #2933.

Citigroup first reported a position in AVNS in Q4 2014 and has held it in 47 quarters since. The position peaked at $3.86M in Q4 2017. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Citigroup held 80,193 shares of Avanos Medical worth $2M as of Q2 2026.
  • Citigroup bought 69,849 Avanos Medical shares in Q2 2026, an estimated $1.64M.
  • Avanos Medical made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2933 holding.
  • Citigroup first reported a position in Avanos Medical in Q4 2014 and has held it in 47 quarters since.
  • Citigroup's Avanos Medical position peaked at $3.86M in Q4 2017.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.